Extracellular myocardial volume in patients with aortic stenosis
<p><strong>Background:</strong> Myocardial fibrosis is a key mechanism of left ventricular decompensation in aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) measures such as extracellular volume fraction (ECV%). Outcomes following aortic...
Autors principals: | Everett, RJ, Treibel, TA, Fukui, M, Lee, H, Rigolli, M, Singh, A, Bijsterveld, P, Tastet, L, Musa, TA, Dobson, L, Chin, C, Captur, G, Om, SY, Wiesemann, S, Ferreira, VM, Piechnik, SK, Schulz-Menger, J, Schelbert, EB, Clavel, M-A, Newby, DE, Myerson, SG, Pibarot, P, Lee, S, Cavalcante, JL, Lee, S-P, McCann, GP, Greenwood, JP, Moon, JC, Dweck, MR |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2020
|
Ítems similars
-
Myocardial scar and mortality in severe aortic stenosis: Data from the BSCMR valve consortium
per: Musa, T, et al.
Publicat: (2018) -
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.
per: Moon, J, et al.
Publicat: (2013) -
Inequity of access to contrast-enhanced cardiovascular magnetic resonance in patients with chronic kidney disease: A survey from the British Society of Cardiovascular Magnetic Resonance
per: William E. Moody, et al.
Publicat: (2025-01-01) -
Accuracy of stroke volume measurement with phase-contrast cardiovascular magnetic resonance in patients with aortic stenosis
per: Ezequiel Guzzetti, et al.
Publicat: (2021-11-01) -
The Effect of Blood Composition on T1 Mapping
per: Rosmini, S, et al.
Publicat: (2019)